IR vs VRDN · P/E 49, rev $7.65B vs rev $425.0K
Ingersoll Rand Inc (IR) versus Viridian Therapeutics Inc (VRDN) — a side-by-side from cached financials, not a winner call.
Ingersoll Rand Inc (IR) is a specialty industrial machinery company listed on US.
Viridian Therapeutics Inc (VRDN) is a biotechnology company listed on US.
Latest reported IR revenue for 2025-12-31 was $7.65B. Net income was $581.4M. IR currently screens at market cap $28.27B and trailing P/E 48.8.
Latest reported VRDN revenue for 2026-06-30 was $425.0K. Net income was -$232.0M. VRDN currently screens at market cap $1.39B.
IR currently screens at market cap $28.27B and trailing P/E 48.8. VRDN currently screens at market cap $1.39B.
Not investment advice. Open the IR and VRDN stock pages for the full models.
Not investment advice.